Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zefeng Xu

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
Hematology (Amsterdam, Netherlands)|April 10, 2024
Combination therapy with venetoclax and azacitidine for the treatment of myelodysplastic syndromes with <i>DDX41</i> mutationsXin Wang, Zhijian Xiao, Tiejun Qin, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 30, 2025
Opportunities for 2D-Material-Based Multifunctional Devices and Systems in Bioinspired Neural NetworksJin Feng Leong, Maheswari Sivan, Jieming Pan, et al.
Experimental Hematology & Oncology|May 14, 2025
A correlation of ineffective erythropoiesis and dysregulated signaling pathways in myelodysplastic syndromes/neoplasmsJunying Wu, Jinqin Liu, Jia Chen, et al.
Nature Communications|September 19, 2025
Ferroelectric-based Pockels photonic memoryZefeng Xu, Chun-Kuei Chen, Hong-Lin Lin, et al.
American Journal of Hematology|February 25, 2025
The Molecular Features of Chronic Eosinophilic Leukemia, Not Otherwise SpecifiedShiqiang Qu, Ningning Liu, Qi Sun, et al.
Hematological Oncology|May 24, 2022
Ruxolitinib combined with prednisone, thalidomide and danazol in patients with myelofibrosis: Results of a pilot studyShiqiang Qu, Zefeng Xu, Tiejun Qin, et al.
Journal of Hematology & Oncology|May 4, 2017
Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosisBing Li, Robert Peter Gale, Zefeng Xu, et al.
Nature Communications|July 2, 2026
Light polarization-based electro-optic memoryQuanzhen Wan, Shi Zhao, Baoshan Tang, et al.
Blood Cancer Journal|April 8, 2025
Molecular characteristics and clinical implications of TP53 mutations in therapy-related myelodysplastic syndromesZefei Bao, Bing Li, Tiejun Qin, et al.
British Journal of Haematology|April 24, 2024
Validation and comparison of 5th edition World Health Organization classification (WHO 2022) and International Consensus Classification proposals for MDS-SFB31Linlin Liu, Bing Li, Zefeng Xu, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Hematology (Amsterdam, Netherlands)|April 10, 2024
Combination therapy with venetoclax and azacitidine for the treatment of myelodysplastic syndromes with <i>DDX41</i> mutationsXin Wang, Zhijian Xiao, Tiejun Qin, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 30, 2025
Opportunities for 2D-Material-Based Multifunctional Devices and Systems in Bioinspired Neural NetworksJin Feng Leong, Maheswari Sivan, Jieming Pan, et al.
Experimental Hematology & Oncology|May 14, 2025
A correlation of ineffective erythropoiesis and dysregulated signaling pathways in myelodysplastic syndromes/neoplasmsJunying Wu, Jinqin Liu, Jia Chen, et al.
Nature Communications|September 19, 2025
Ferroelectric-based Pockels photonic memoryZefeng Xu, Chun-Kuei Chen, Hong-Lin Lin, et al.
American Journal of Hematology|February 25, 2025
The Molecular Features of Chronic Eosinophilic Leukemia, Not Otherwise SpecifiedShiqiang Qu, Ningning Liu, Qi Sun, et al.
Hematological Oncology|May 24, 2022
Ruxolitinib combined with prednisone, thalidomide and danazol in patients with myelofibrosis: Results of a pilot studyShiqiang Qu, Zefeng Xu, Tiejun Qin, et al.
Journal of Hematology & Oncology|May 4, 2017
Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosisBing Li, Robert Peter Gale, Zefeng Xu, et al.
Nature Communications|July 2, 2026
Light polarization-based electro-optic memoryQuanzhen Wan, Shi Zhao, Baoshan Tang, et al.
Blood Cancer Journal|April 8, 2025
Molecular characteristics and clinical implications of TP53 mutations in therapy-related myelodysplastic syndromesZefei Bao, Bing Li, Tiejun Qin, et al.
British Journal of Haematology|April 24, 2024
Validation and comparison of 5th edition World Health Organization classification (WHO 2022) and International Consensus Classification proposals for MDS-SFB31Linlin Liu, Bing Li, Zefeng Xu, et al.
Pageof 13